CXCL12 and breast cancer: The NF-κB signaling pathway is downstream of the CXCL12/CXCR4 axis, and its activation contributes to cancer cell survival and invasion in various types of cancer, including prostate [39], pancreatic [40], lung [41], and breast cancer [42].